Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Total Non-Current Liabilities (2016 - 2026)

Insmed's Total Non-Current Liabilities history spans 17 years, with the latest figure at $1.4 billion for Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 9.96% to $1.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Mar 2026, down 9.96% year-over-year, with the annual reading at $1.2 billion for FY2025, 22.9% down from the prior year.
  • Total Non-Current Liabilities came in at $1.4 billion for Q1 2026, up from $1.2 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.8 billion in Q2 2024 to a low of $953.5 million in Q2 2022.
  • The 5-year median for Total Non-Current Liabilities is $1.5 billion (2025), against an average of $1.4 billion.
  • Year-over-year, Total Non-Current Liabilities soared 106.12% in 2022 and then tumbled 30.38% in 2025.
  • Insmed's Total Non-Current Liabilities stood at $1.6 billion in 2022, then increased by 1.03% to $1.6 billion in 2023, then dropped by 0.39% to $1.6 billion in 2024, then dropped by 22.9% to $1.2 billion in 2025, then increased by 12.72% to $1.4 billion in 2026.
  • Per Business Quant, the three most recent readings for INSM's Total Non-Current Liabilities are $1.4 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.4 billion (Q3 2025).